CARI REESE: Open Payments
NPI 1356417083 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,179 in 65 payments from 11 companies in 2025. Trend: 2023 $622 · 2024 $912 · 2025 $1,179
Food & beverage: $1,106Education: $73
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $318 |
| Janssen Biotech, Inc. | 16 | $253 |
| ABBVIE INC. | 12 | $181 |
| Regeneron Healthcare Solutions, Inc. | 5 | $107 |
| LEO Pharma Inc. | 3 | $74 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $58 |
| Lilly USA, LLC | 2 | $48 |
| GENZYME CORPORATION | 2 | $48 |
| UCB, Inc. | 2 | $39 |
| PFIZER INC. | 2 | $32 |
Products named: TREMFYA, COSENTYX, DUPIXENT, SKYRIZI, RINVOQ, ADBRY, ILUMYA, TALTZ.
Industry payments across NV — which companies pay providers there.
